{"organizations": [], "uuid": "2238e5ec45935f5a308f9ca0c7ee86b6e7b82cd7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180124.html", "section_title": "Archive News &amp; Video for Wednesday, 24 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-novartis-generics-head-sees-us-pri/brief-novartis-generics-head-sees-u-s-price-pressure-in-2018-idUSZ8N15A01N", "country": "US", "domain_rank": 408, "title": "BRIEF-Novartis generics head sees U.S. price pressure in 2018", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.022, "site_type": "news", "published": "2018-01-24T22:38:00.000+02:00", "replies_count": 0, "uuid": "2238e5ec45935f5a308f9ca0c7ee86b6e7b82cd7"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-novartis-generics-head-sees-us-pri/brief-novartis-generics-head-sees-u-s-price-pressure-in-2018-idUSZ8N15A01N", "ord_in_thread": 0, "title": "BRIEF-Novartis generics head sees U.S. price pressure in 2018", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "zurich", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "novartis", "sentiment": "negative"}, {"name": "sandoz", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 24 (Reuters) - Novartis:\n* SANDOZ HEAD SAYS U.S. PRICING PRESSURE TO CONTINUE IN 2018, WILL ABATE AS BIOSIMILARS COME THROUGH IN COMING YEARS\n* CEO SAYS CONTINUES TO EXPECT BIOSIMILARS TO BE A MULTI-BILLION DOLLAR BUSINESS, BUT MUST OVERCOME PATENT HURDLES IN UNITED STATES Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-24T22:38:00.000+02:00", "crawled": "2018-01-25T13:10:51.051+02:00", "highlightTitle": ""}